#######################
# Document Properties #
#######################

SET DOCUMENT Licenses    = "MIT License"
SET DOCUMENT ContactInfo = "farah.humayun@scai-extern.fraunhofer.de"

SET DOCUMENT Name        = "heme_30281034.bel"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Farah Humayun"
SET DOCUMENT Description = "Heme BEL model is a disease model based on Biological Expression Language (BEL) containing the core mechanisms of heme as modulator in Hemolytic diseases such as sickle-cell anemia, beta-thalassemia, malaria and autoimmune hemolytic anemia."

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns"
DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns"
DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns"
# DEFINE NAMESPACE FB           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/80171ae62cf43aa1fc8a6c326b94537ab342458c/external/fb-names.belns"
DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns"
DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns"
DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns"
DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns"
DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns"
DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns"
DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"

# Namespaces hosted on https://arty.scai.fraunhofer.de/artifactory/bel/namespace
# ------------------------------------------------------------------------------
DEFINE NAMESPACE CTO            AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns"
DEFINE NAMESPACE DO             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns"
DEFINE NAMESPACE HP             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"
DEFINE NAMESPACE SCOMP          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns"
DEFINE NAMESPACE SFAM           AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

DEFINE NAMESPACE HM        AS PATTERN ".*"


###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN ".*"
DEFINE ANNOTATION TimePoint     AS PATTERN ".*"
DEFINE ANNOTATION Concentration     AS PATTERN ".*"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############

SET Citation = {"PubMed", "Curr Opin Hematol. 2018 Nov;25(6):452-458. doi: 10.1097/MOH.0000000000000458.", "30281034"} 

SET TextLocation = "Review"

SET Evidence = "There is a clear need
for, and medical benefit from, blood transfusions;
nonetheless, administration of red blood cells
(RBCs) does result in exposure to toxicants specific
to hemoglobin (Hb) and its degradation components,
hemin and iron."

a(MESH:"Blood Transfusion") -> p(HGNC:HBB)
a(MESH:"Blood Transfusion") -> a(CHEBI:heme)
a(MESH:"Blood Transfusion") -> a(CHEBI:"iron(2+)")

SET Evidence = "The causes for RBC-based
toxicant exposures are multifactorial; however, following
acute transfusion, the most common occurs
during the processes of extravascular hemolysis,
which includes macrophage erythrophagocytosis
followed by macrophage death [1&&], release of iron,
transferrin (Tf) saturation and, finally, accumulation
of labile plasma iron (LPI) [2]."

SET Cell = "erythrocyte"
a(HM:"Blood Transfusion, Acute") -> bp(MESH:Phagocytosis)
bp(MESH:Phagocytosis) -> bp(GO:"macrophage apoptotic process")
bp(MESH:Phagocytosis) -> a(CHEBI:"iron(2+)")
bp(MESH:Phagocytosis) -> path(HP:"Elevated transferrin saturation")
bp(MESH:Phagocytosis) -> a(HM:"Labile iron", loc(MESH:Plasma))

SET Evidence = "Conversely, chronic transfusions associated with
b-thalassemia major and sickle cell disease lead to
hemochromatosis with end organ injury."

a(HM:"Blood Transfusion, Chronic") -> path(MESH:Hemochromatosis)

SET Evidence = "For example, Hb and
subsequently, hemin accumulate during storage of
human blood as RBC membrane integrity decreases
[4]."

a(HM:"stored erythrocytes") -> bp(MESH:"Erythrocyte Deformability")

SET Evidence = "Tf is an
abundant plasma glycoprotein that normally circulates
at a high concentration (2â€“4mg/ml) to prevent
accumulation of LPI."

p(HGNC:TF) -| a(HM:"Labile iron", loc(MESH:Plasma))

SET Evidence = "The pool
of di-ferric Tf binds to erythroid cell transferrin
receptor 1 (TfR1) and contributes to erythropoiesis
[16]."

complex(a(MESH:"diferric transferrin"), p(HGNC:TFRC)) -> bp(MESH:Erythropoiesis)

SET Evidence = "Acute large volume blood transfusion
or administration of blood units at later
stages of storage causes elevation of bilirubin, Tf
saturation and LPI in animals [18&&] and humans
[19&&]."

a(HM:"Blood Transfusion, Acute") -> a(CHEBI:bilirubin)
a(HM:"Blood Transfusion, Acute") -> path(HP:"Elevated transferrin saturation")
a(HM:"Blood Transfusion, Acute") -> a(HM:"Labile iron", loc(MESH:Plasma))

SET Evidence = "Accumulation of iron in tissue parenchyma with
subsequent hemochromatosis is a well-known problem
in chronic transfusion-dependent diseases such
as b-thalassemia major, and in sickle cell disease
patients when stroke prevention is indicated."

SET MeSHDisease = {"beta-Thalassemia", "Anemia, Sickle Cell"}
a(HM:"Blood Transfusion, Chronic") -> path(MESH:Hemochromatosis)

SET Evidence = "For example, cardiac iron accumu
-lation is more common in transfused thalassemia
patients, whereas liver iron accumulation is most
common in transfused sickle cell disease patients."

SET MeSHDisease = "beta-Thalassemia"
a(HM:"Blood Transfusion, Chronic") -> a(MESH:Iron , loc(MESH:Heart))
SET MeSHDisease = "Anemia, Sickle Cell"
a(HM:"Blood Transfusion, Chronic") -> a(MESH:Iron , loc(MESH:Liver))

SET Evidence = "Because of large exposures to iron that occur in
both disorders following transfusion, patients are
inevitably prescribed small molecule iron chelation
and the concomitant monitoring that is required."

SET MeSHDisease = {"beta-Thalassemia", "Anemia, Sickle Cell"}

a(MESH:"Iron Chelating Agents") -| a(CHEBI:"iron(2+)")

SET Evidence = "Sequestration of LPI and prevention of pro-oxidative
effects by the administration of apo-Tf may
have clinical relevance following acute and chronic
transfusion iron overload."

p(HGNC:TF) -| a(HM:"Labile iron", loc(MESH:Plasma))

SET Evidence = "These studies do begin
to suggest that apo-Tf administration could attenuate
acute iron overload and hemochromatosis progression
following chronic RBC transfusions."

p(HGNC:TF) -| a(CHEBI:"iron(2+)")
p(HGNC:TF) -| path(MESH:Hemochromatosis)

SET Evidence = "Of the biological components known to bind
hemin, Hpx is by far the most efficient with a
dissociation constant (Kd) lower than 1 x 10â€“13 M;
as a result, after binding, the transfer of hemin from
Hpx to other proteins or lipids is not possible [24]."

p(HGNC:HPX) -| a(CHEBI:heme)

SET Evidence = "Once bound to
hemin, the Hpx-hemin complex prevents oxidative
reactions and facilitates clearance of the complex
through macrophage CD91, also referred to as lowdensity
lipoprotein receptor-related protein 1."

complex(p(HGNC:HPX), a(CHEBI:hemin)) -| a(HM:"oxidative reactions")

SET Evidence = "In mice, this response was
attenuated after administration of the TLR-4 inhibitor,
TAK-242, suggesting hemin potentiates pulmonary
macrophage activation and inflammation
through hemin-induced TLR-4 receptor binding
[27]."

a(CHEBI:heme) -> p(HGNC:TLR4)
a(CHEBI:heme) -> bp(MESH:"Macrophage Activation")
a(CHEBI:heme) -> path(MESH:Inflammation)

SET Evidence = "Hp
is a plasma glyco-protein that normally circulates in
within a concentration range of 0.3â€“2mg/ml and is
the putative scavenger of cell-free Hb with a high
affinity (KDÂ¼10â€“12M) for Hb dimers (Fig. 1 A,B and
Fig. 2 C [31])."

p(HGNC:HP) -| p(HGNC:HBB)

SET Evidence = "In diseases of intravascular hemolysis,
Hp is often not detectable and lower Hp levels
are associated with transfusion."

a(MESH:"Blood Transfusion") -| p(HGNC:HP)

UNSET TextLocation
################